Evidence map›Paper›PMID 35617253›Full record

ArticlePloS one2022

Health care expenditures among long-term survivors of pediatric solid tumors: Results from the French Childhood Cancer Survivor Study (FCCSS) and the French network of cancer registries (FRANCIM).

Daniel Bejarano-Quisoboni, Nathalie Pelletier-Fleury, Rodrigue S Allodji, Brigitte Lacour, Pascale GrosClaude, FRANCIM Group, Hélène Pacquement, François Doz, Delphine Berchery, Claire Pluchart and 11 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Excess healthcare expenditure in adults treated for solid cancer in childhood: a cohort study in France.The European journal of health economics : HEPAC : health economics in prevention and care · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 1 country.

Daniel Bejarano-QuisoboniRadiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.
Nathalie Pelletier-FleuryPrimary care and Prevention Team, CESP, Inserm U1018, Villejuif, France.
Rodrigue S AllodjiRadiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.
Brigitte LacourEPICEA, CRESS, INSERM UMR 1153, Université de Paris, Paris, France.
Pascale GrosClaudeINSERM U1027, Toulouse, France.
FRANCIM Group
Hélène PacquementSIREDO Center (Care, Research, Innovation in Pediatric, Adolescents and Young Adults Oncology), Institut Curie, Paris, France.
François DozSIREDO Center (Care, Research, Innovation in Pediatric, Adolescents and Young Adults Oncology), Institut Curie, Paris, France.
Delphine BercheryEpidemiology Unit, Claudius Regaud Institute, Toulouse, France.
Claire PluchartPediatric Oncology, Reims, France.
Piere-Yves BondiauRadiation Therapy, Antoine Lacassagne Cancer Center, Nice, France.
Julie NysRadiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.
Angela JacksonRadiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.
Charlotte Demoor-GoldschmidtRadiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.
Agnès DumasUniversité de Paris, ECEVE, UMR1123, Inserm, Paris, France.
Cécile Thomas-TeinturierRadiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.ORCID 0000-0003-4821-967X
Giao Vu-BezinRadiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.
Dominique Valteau-CouanetDepartment of Children and Adolescent Oncology, Gustave Roussy, Villejuif, Paris, France.
Nadia HaddyRadiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.
Brice FresneauRadiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.
Florent de VathaireRadiation Epidemiology Team, CESP, Inserm U1018, Villejuif, France.ORCID 0000-0002-8374-9281
Inserm · FRL’Institut du Cancer Courlancy Reims · FRUniversité Paris Cité · FRInstitut Curie · FRUniversité Toulouse III - Paul Sabatier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChildhood cancer survivors (CCS) may require lifelong medical care due to late effects of cancer treatments. Little is known about of their healthcare utilization and expenditures at long-term especially in publicly funded health care system. We aim to estimate and describe the health care expenditures among long-term CCS in France.

methodsA total of 5319 five-year solid CCS diagnosed before the age of 21 between 1945 and 2000 in France were identified in the French Childhood Cancer Survivors Study cohort (FCCSS) and the French cancer registry. Information about health care expenditure was taken from the French national health data system between 2011 and 2016, and was described according to survivors' characteristics. Generalized linear models were used to determine associations between health care expenditures and survivors' characteristics.

resultsMean annual amount of healthcare expenditures was € 4,255. Expenditures on hospitalizations and pharmacy represents 60% of total expenditures. Mean annual of healthcare expenditures were higher at increasing age, among women survivors (€ 4,795 vs € 3,814 in men) and in central nervous system (CNS) tumor survivors (€ 7,116 vs € 3,366 in lymphoma and € 3,363 in other solid tumor survivors).

conclusionsChildhood cancer survivorship is associated with a substantial economic burden in France. We found that female gender and CNS primary cancer were associated with increased healthcare expenditures.

Indexed as

Cancer SurvivorsNeoplasmsChildFemaleHealth ExpendituresHumansMaleRegistriesSurvivors

Identifiers

PMID35617253
PMCPMC9135272
OpenAlexW4281567275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.